Share-based Payment Arrangement, Expense in USD of Surface Oncology, Inc. from 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Surface Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2016 to Q2 2023.
  • Surface Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2023 was $1.19M, a 42.8% decline year-over-year.
  • Surface Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2023 was $6.12M, a 21.8% decline year-over-year.
  • Surface Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.22M, a 15.5% decline from 2021.
  • Surface Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.55M, a 10.1% increase from 2020.
  • Surface Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $7.77M, a 29.6% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Surface Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $6.12M $1.19M -$887K -42.8% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023
Q1 2023 $7M $1.65M -$219K -11.7% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $7.22M $1.52M -$324K -17.6% 01 Oct 2022 31 Dec 2022 8-K 03 Jul 2023
Q3 2022 $7.55M $1.77M -$278K -13.6% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 $7.83M $2.07M -$206K -9.04% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 $8.03M $1.87M -$515K -21.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $8.55M $1.84M -$109K -5.58% 01 Oct 2021 31 Dec 2021 8-K 03 Jul 2023
Q3 2021 $8.66M $2.04M +$81K +4.13% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $8.57M $2.28M +$279K +14% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $8.3M $2.38M +$530K +28.6% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $7.77M $1.95M +$407K +26.3% 01 Oct 2020 31 Dec 2020 8-K 03 Jul 2023
Q3 2020 $7.36M $1.96M +$397K +25.4% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $6.96M $2M +$515K +34.7% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 $6.45M $1.85M +$455K +32.6% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $5.99M $1.55M +$323K +26.4% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2022
Q3 2019 $5.67M $1.57M +$352K +29% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $5.32M $1.49M -$5K -0.34% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $5.32M $1.4M +$104K +8.06% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q4 2018 $5.22M $1.22M 01 Oct 2018 31 Dec 2018 10-K 09 Mar 2021
Q3 2018 $1.21M 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $1.49M 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $1.29M 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019

Surface Oncology, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7.22M -$1.32M -15.5% 01 Jan 2022 31 Dec 2022 8-K 03 Jul 2023
2021 $8.55M +$781K +10.1% 01 Jan 2021 31 Dec 2021 8-K 03 Jul 2023
2020 $7.77M +$1.77M +29.6% 01 Jan 2020 31 Dec 2020 8-K 03 Jul 2023
2019 $5.99M +$774K +14.8% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022
2018 $5.22M +$508K +10.8% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021
2017 $4.71M +$3.36M +250% 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020
2016 $1.35M 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.